Cardiovascular System Flashcards
Class Ia
Sodium Channel Blockers
(Anti-arrhythmic Drugs)
Disopyramide, Quinidine
MoA:
Voltage-sensitive sodium channel blockade
Prolong QT interval, increase QRS duration.
Indication:
Ventricular and supraventricular arrhythmias
Adverse Effects/Interaction:
Oedema
Class Ib
Sodium Channel Blockers
(Anti-arrhythmic Drugs)
Lidocaine
MoA:
Voltage-sensitive sodium channel blockade
Prolong QT interval, increase QRS duration.
Indication:
CPR (used IV)
Adverse Effects/Interaction:
Oedema
Class Ic
Sodium Channel Blockers
(Anti-arrhythmic Drugs)
Flecainide, Propafenone
MoA:
Voltage-sensitive sodium channel blockade
Prolong QT interval, increase QRS duration.
Indication:
Paroxysmal atrial fibrillation and ventricular ectopic beats “pill in pocket”
Adverse Effects/Interaction:
Oedema
Class II
Beta blockers
(Beta-adrenergic antagonists)
(Anti-arrhythmic Drugs)
Bisoprolol, Atenolol (Beta-1 selective); Propranolol (Beta-1 & Beta-2 selective)
MoA:
Beta-adrenergic receptor blockade – reduction in adrenergic effects on rate and inotropy
Indication:
Prophylaxis of paroxysmal atrial tachycardia or fibrillation
Adverse Effects/Interaction:
Hypotension
Class III
Potassium Channel Blockers
(Anti-arrhythmic Drugs)
Amiodarone, Dronedarone, Sotalol (Sotalol also has some beta blocker activity)
MoA:
Potassium channel blockade, also evidence of beta blocker and calcium channel blocker properties – prolong QT interval
Indication:
Supraventricular, nodal and ventricular tachyarrhythmias, atrial fibrillation
(CPR - used IV)
Adverse Effects/Interaction:
Nausea, vomiting
Class IV
Calcium Channel Blockers (phenylalkylamine & benzothiazepine subclasses
(Anti-arrhythmic Drugs)
Verapamil, Diltiazem (for arrhythmia)
MoA:
Cardiac calcium channel blockade – reduction of action potential & cardiac output
Indication: Supraventricular tachycardia (especially paroxysmal SVT)
Adverse Effects/Interaction:
Hypotension (verapamil)
Constipation (diltiazem)
Cardiac Glycosides
Anti-arrhythmic Drugs
Digoxin
MoA:
Reduces conductivity of atrioventricular node
Indication:
Arrhythmias – atrial fibrillation, congestive heart failure
Adverse Effects/Interaction:
Fatigue, nausea
Adenosine
Anti-arrhythmic Drugs
Adenosine
MoA:
Activates adenosine receptors – causes hyperpolarization
Slows conduction through AV Node
Indication:
Supraventricular tachycardia
Adverse Effects/Interaction:
Nausea
*contraindicated in obstructive airway disease
Antimuscarinic
Anti-arrhythmic Drugs
Atropine
MoA:
Blockade of vagal muscarinic acetylcholine receptors
Indication:
Emergency bradycardia
Adverse Effects/Interaction:
Urinary retention
Magnesium
Anti-arrhythmic Drugs
Magnesium sulfate (intravenous)
MoA:
Unclear – possible alteration of Na+, K+ and Ca2+ ion balance via ion channels and transporters
Indication:
Emergency arrhythmia
(Also used IV for emergency asthma)
Adverse Effects/Interaction:
Electrolyte irregularities
Loop Diuretics
Diuretics
Furosemide
MoA:
Inhibits Na+/K+/2Cl- transporter in loop of Henle
Indication:
Left ventricular heart failure, oedema
Adverse Effects/Interaction:
Nausea, dizziness
NSAIDs, ACE inhibitors
Thiazides
Diuretics
Indapamide
Bendroflumethiazide
Chlorthalidone
Hydrochlorothiazide
MoA:
Decreases sodium and chloride reabsorption
Indication:
Hypertension
Adverse Effects/Interaction:
Electrolyte imbalance, exacerbation or precipitation of gout
NSAIDs, digoxin
Potassium Sparing Diuretics
Diuretics
Spironolactone, Epleronone
Amiloride
MoA:
Mineralocorticoid receptor blockade (spironolactone, epleronone)
Blockade of sodium reabsorption via ENaC channel (amiloride)
Indication:
Oedema, congestive heart failure
Adverse Effects/Interaction:
Gastrointestinal
NSAIDs, ACE inhibitors
Osmotic Diuretics
Diuretics
Mannitol
MoA:
Elevates plasma osmolarity
Indication:
Cerebral oedema, intra-ocular pressure
Adverse Effects/Interaction:
Hypotension
Carbonic Anhydrase Inhibitors
Diuretics
Acetazolamide
MoA:
Reduces aqueous humour volume
Indication:
Intra-ocular pressure – open & acute closed angle glaucoma
Adverse Effects/Interaction:
Paraesthesia